Mechanistic studies of the skin delivery of lipid colloid systems with different oil/fatty ester ratios for both lipophilic and hydrophilic drugs

Current Nanoscience

Volumn 7, Issue 2, 2011, Pages 200-209

  Hsu, Shu Hui ^a   Al Suwayeh, Saleh A ^b   Hung, Chi Feng ^c   Tsai, Chia Yin ^d   Fang, Jia You ^b,d,e  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Calcipotriol; Drug delivery; Lipid colloid systems; Methotrexate; Skin

Indexed keywords

AQUEOUS PHASE; CALCIPOTRIOL; CELLULOSE MEMBRANES; COLLOID SYSTEMS; COLLOIDAL SYSTEM; CONFOCAL LASER SCANNING; DRUG PERMEATION; ESTER RATIO; HYDROPHILIC DRUGS; IN-VITRO; IN-VIVO; INNER PHASE; LIPID CORES; LIPID EMULSIONS; LIPOPHILIC DRUGS; LIPOPHILICITY; MAJOR FACTORS; MECHANISTIC STUDIES; METHOTREXATE; MOUSE SKIN; NANOSTRUCTURED LIPID CARRIERS; NEGATIVE ZETA POTENTIALS; NUDE MICE; PERMEATION ENHANCEMENT; RELEASE RATE; SKIN DELIVERY; SKIN PERMEATION; SOLID LIPID NANOPARTICLES; TRANSEPIDERMAL WATER LOSS;

COREMAKING; DRUG DELIVERY; DRUG PRODUCTS; ESTERS; HYDROPHILICITY; NANOPARTICLES; ZETA POTENTIAL;

COLLOIDS;

CALCIPOTRIOL; CELLULOSE; GLYCEROL PALMITOSTEARATE; LIPID EMULSION; METHOTREXATE; SOLID LIPID NANOPARTICLE; SQUALENE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLLOID; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; ENCAPSULATION; FEMALE; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SKIN; SKIN PERMEABILITY; SKIN WATER LOSS; ZETA POTENTIAL;

MUS MUSCULUS;

EID: 79951710480     PISSN: 15734137     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341311794653712     Document Type: Article

References (41)

1. Williams, A.C.; Barry, B.W. Penetration enhancers. Adv. Drug Deliv. Rev., 2004, 56, 603-618.
2. Pople, P.V.; Singh, K.K. Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A. AAPS PharmSciTech., 2006, 7, 91.
3. Nakano, M. Places of emulsions in drug delivery. Adv. Drug Deliv. Rev., 2000, 45, 1-4.
4. Pardeike, J.; Hommoss, A.; Müller, R.H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm., 2009, 366, 170-184.
5. Müller, R.H.; Petersen, R.D.; Hommoss, A.; Pardeike, J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv. Drug Deliv. Rev., 2007, 59, 522-530.
6. Fang, J.Y.; Fang, C.L.; Liu, C.H.; Su, Y.H. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur. J. Pharm. Biopharm., 2008, 70, 633-640.
7. Junyaprasert, V.B.; Teeranachaideekul, V.; Souto, E.B.; Boonme, P.; Müller, R.H. Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation. Int. J. Pharm., 2009, 377, 207-214.
8. Küchler, S.; Abdel-Mottaleb, M.; Lamprecht, A.; Radowski, M.R.; Haag, R.; Schäfer-Korting, M. Influence of nanocarrier type and size on skin delivery of hydrophilic agents. Int. J. Pharm., 2009, 377, 169-172.
9. Witman, P.M. Topical therapies for localized psoriasis. Mayo Clin. Proc., 2001, 76, 943-949.
10. Su, Y.H.; Fang, J.Y. Drug delivery and formulations for the topical treatment of psoriasis. Expert Opin. Drug Deliv., 2008, 5, 235-249.
11. Baroli, B.; López-Quintela, M.A.; Delgado-Charro, M.B.; Fadda, A.M.; Blanco-Méndez, J. Microemulsions for topical delivery of 8-methoxsalen. J. Control. Release, 2000, 69, 209-218.
12. Dubey, V.; Mishra, D.; Dutta, T.; Nahar, M.; Saraf, D.K.; Jain, N.K. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J. Control. Release, 2007, 123, 148-154.
13. Li, L.; Hoffman, R.M. Topical liposome delivery of molecules to hair follicles in mice. J. Dermatol. Sci., 1997, 14, 101-108.
14. Lee, W.R.; Shen, S.C.; Wang, K.H.; Hu, C.H.; Fang, J.Y. The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil. J. Pharm. Sci., 2002, 91, 1613-1626.
15. Jenning, V.; Thünemann, A.F.; Gohla, S.H. Characterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int. J. Pharm., 2000, 199, 167-177.
16. Puglia, C.; Blasi, P.; Rizza, L.; Schoubben, A.; Bonina, F.; Rossi, C.; Ricci, M. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int. J. Pharm., 2008, 357, 295-304.
17. Wang, J.J.; Liu, K.S.; Sung, K.C.; Tsai, C.Y.; Fang, J.Y. Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers, and solid lipid nanoparticles. J. Microencapsul., 2009, 26, 734-747.
18. Müller, R.H.; Mäder, K.; Gohla, S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Bio-pharm., 2000, 50, 161-177.
19. Wong, H.L.; Bendayan, R.; Rauth, A.M.; Wu, X.Y. Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers. J. Pharm. Sci., 2004, 93, 1993-2008.
20. Chen, H.; Chang, X.; Du, D.; Liu, W.; Liu, J.; Weng, T.; Yang, Y.; Xu, H.; Yang, X. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J. Control. Release, 2006, 110, 296-306.
21. Wong, T.W.; Chen, C.H.; Huang, C.C.; Lin, C.D.; Hui, S.W. Painless electroporation with a new needle-free microelectrode array to enhance transdermal drug delivery. J. Control. Release, 2006, 110, 557-565.
22. Baroli, B. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? J. Pharm. Sci., 2010, 99, 21-50.
23. Teeranachaideekul, V.; Boonme, P.; Souto, E.B.; Müller, R.H.; Junyaprasert, V.B. Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J. Control. Release, 2008, 128, 134-141.
24. Schäfer-Korting, M.; Mehnert, W.; Korting, H. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug Deliv. Rev., 2007, 59, 427-443.
25. Cevc, G. Lipid vesicles and other colloids as drug carriers on the skin. Adv. Drug Deliv. Rev., 2004, 56, 675-711.
26. Mandawgade, S.D.; Patravale, V.B. Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int. J. Pharm., 2008, 363, 132-138.
27. Liu, J.; Hu, W.; Chen, H.; Ni, Q.; Xu, H.; Yang, X. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm., 2007, 328, 191-195.
28. Lombardi Borgia, S.; Regehly, M.; Sivaramakrishnan, R.; Mehnert, W.; Korting, H.C.; Danker, K.; Röder, B.; Kramer, K.D.; Schäfer-Korting, M. Lipid nanoparticles for skin penetration enhancement - correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J. Control. Release, 2005, 110, 151-163.
29. Wissing, S.A.; Müller, R.H. Solid lipid nanoparticles as carrier for sun-screens: in vitro release and in vivo skin penetration. J. Control. Release, 2002, 81, 225-233.
30. Pathak, P.; Nagarsenker, M. Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery. AAPS PharmSciTech., 2009, 10, 985-992.
31. Wang, J.J.; Liu, K.S.; Sung, K.C.; Tsai, C.Y.; Fang, J.Y. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. Eur. J. Pharm. Sci., 2009, 38, 138-146.
32. Huang, Z.R.; Lin, Y.K.; Fang, J.Y. Biological and pharmacological activities of squalene and related compounds: potential uses in cosmetic dermatology. Molecules, 2009, 14, 540-554.
33. Alvarez-Román, R.; Naik, A.; Kalia, Y.N.; Fessi, H.; Guy, R.H. Visualization of skin penetration using confocal laser scanning microscopy. Eur. J. Pharm. Biopharm., 2004, 58, 301-316.
34. Lv, Q.; Yu, A.; Xi, Y.; Li, H.; Song, Z.; Cui, J.; Cao, F.; Zhai, G. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int. J. Pharm., 2009, 372, 191-198.
35. tacová, J.; Mehnert, W.; Blaschke, T.; Kleuser, B.; Sivaramakrishnan, R.; Zouboulis, C.C.; Seltmann, H.; Korting, H.C.; Kramer, K.D.; SchäferKorting, M. Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterization and skin uptake. Pharm. Res., 2007, 24, 991-1000.
36. Rancan, F.; Papakostas, D.; Hadam, S.; Hackbarth, S.; Delair, T.; Primard, C.; Verrier, B.; Sterry, W.; Blume-Peytavi, U.; Vogt, A. Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy. Pharm. Res., 2009, 26, 2027-2036.
37. Knorr, F.; Lademann, J.; Patzelt, A.; Sterry, W.; Blume-Peytavi, U.; Vogt, A. Follicular transport route - research progress and future perspectives. Eur. J. Pharm. Biopharm., 2009, 71, 173-180.
38. Sung, K.C.; Fang, J.Y.; Wang, J.J.; Hu, O.Y.P. Transdermal delivery of nalbuphine and its prodrugs by electroporation. Eur. J. Pharm. Sci., 2003, 18, 63-70.
39. Jung, S.; Patzelt, A.; Otberg, N.; Thiede, G.; Sterry, W.; Lademann, J. Strategy of topical vaccination with nanoparticles. J. Biomed. Opt., 2009, 14, 021001.
40. Zhao, K.; Singh, J. Mechanisms of in vitro percutaneous absorption enhancement of tamoxifen by enhancers. J. Pharm. Sci., 2000, 89, 771-780.
41. Serup, J.; Agner, T. Colorimetric quantification of erythema - a comparison of two colorimeters (Lange Micro Color and Minolta Chroma Meter CR-200) with a clinical scoring scheme and laser-Doppler flowmetry. Clin. Exp. Dermatol., 1990, 15, 267-272.